You are here

  • Home
  • Archive
  • Volume 8, Issue Suppl 3
  • 572 Fibroblast activating protein (FAP)-targeting IL-12 (anti-FAP/IL-12) TMEkine™ potentiates anti-cancer effects in preclinical cancer models

Article metrics

Article menu

Download PDFPDF

Regular and young investigator award abstracts
Immune-stimulants and immune modulators
572 Fibroblast activating protein (FAP)-targeting IL-12 (anti-FAP/IL-12) TMEkine™ potentiates anti-cancer effects in preclinical cancer models

 

Online download statistics by month:

Online download statistics by month: November 2020 to June 2025

AbstractFullPdf
Nov 2020134015
Dec 202035012
Jan 20213105
Feb 20213204
Mar 2021106025
Apr 2021100019
May 20212908
Jun 20210015
Jul 2021008
Aug 20210020
Sep 20210016
Oct 202162035
Nov 202148025
Dec 20213003
Jan 202260012
Feb 202252018
Mar 202228020
Apr 202242015
May 202258014
Jun 20224208
Jul 20222206
Aug 202262016
Sep 202298012
Oct 20224404
Nov 20224805
Dec 2022162027
Jan 202384012
Feb 20237607
Mar 20234404
Apr 202340014
May 20233609
Jun 20232403
Jul 20233605
Aug 20233208
Sep 20238405
Oct 20237805
Nov 20236007
Dec 20234804
Jan 20242001
Feb 20244006
Mar 20244602
Apr 20244406
May 20244806
Jun 20243801
Jul 20244205
Aug 20244805
Sep 20244805
Oct 20241803
Nov 20242405
Dec 20242004
Jan 20252009
Feb 2025406
Mar 2025105
Apr 2025009
May 2025006
Jun 2025005
Total24280539